Biote CEO Terry Weber moved to Dallas from Orange County, Calif., in 2018 to lead the hormone replacement therapy provider into its next stage of growth. The Irving-based company is expecting up to ...

"Biote’s first quarter results benefited from efficiencies related to the vertical integration of our 503B manufacturing facility as well as growth in our dietary supplements business," said Bret ...

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today ...

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today ...

Biote Corp (NASDAQ:BTMD) reported a 4.7% increase in total revenue for the first quarter of 2025. The company's dietary supplements business showed strong performance, with a 25.5% increase in revenue ...

Biote Corp (BTMD) reported its Q1 2025 earnings, surpassing Wall Street expectations with an EPS of $0.37, compared to the forecast of $0.14. The company’s revenue reached $49 million, exceeding the ...

IRVING, Texas--(BUSINESS WIRE)-- Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today ...